Biblio
“Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany.”, J Alzheimers Dis, vol. 58, no. 1, pp. 37-44, 2017.
, “Association Between the Use of Antihyperglycemic Drugs and Dementia Risk: A Case-Control Study.”, J Alzheimers Dis, vol. 66, no. 2, pp. 725-732, 2018.
, “Body Mass Index and Mild Cognitive Impairment Among Middle-Aged and Older Adults from Low- and Middle-Income Countries.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1095-1105, 2021.
, “Is Dementia Associated with COVID-19 Mortality? A Multicenter Retrospective Cohort Study Conducted in 50 Hospitals in Germany.”, J Alzheimers Dis, vol. 91, no. 2, pp. 719-726, 2023.
, “How Different are Quality of Life Ratings for People with Dementia Reported by Their Family Caregivers from Those Reported by the Patients Themselves?”, J Alzheimers Dis, vol. 55, no. 1, pp. 259-267, 2017.
, “Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany.”, J Alzheimers Dis, vol. 65, no. 2, pp. 401-407, 2018.
, “The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany.”, J Alzheimers Dis, vol. 64, no. 3, pp. 827-833, 2018.
, “Persistence with Antihypertensive Drugs in Patients with Hypertension and Dementia in Germany.”, J Alzheimers Dis, vol. 60, no. 2, pp. 505-510, 2017.
, “Prevalence of Use of Cardiovascular Drugs in Dementia Patients Treated in General Practices in Germany.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1519-1524, 2017.
, “Risk Factors for Mild Cognitive Impairment in German Primary Care Practices.”, J Alzheimers Dis, vol. 56, no. 1, pp. 379-384, 2017.
,